Occupational Medicines Market Growth Analysis & Key Business Strategies by Leading Industry Players [Amgen, AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Nestl, Novartis AG, Pfizer, Inc., and Sanofi]

The global occupational medicines market was valued at $3,753 million in 2017, and is estimated to reach $5,794 million by 2025, registering a CAGR of 5.5% from 2018 to 2025. Occupational medicine is a branch of clinical medicine that specializes in treatment of diseases and injuries of people, owing to their work environment. Certain work environment conditions, such as exposure to carcinogenic chemicals and asbestos, cause diseases, such as asthma and cancer. Occupational medicines are prescribed to prevent or treat such diseases and conditions.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4728

Occupational medicine is a branch of medicine concerned with treatment of work-related diseases; for instance, exposure to second-hand smoke and cancer-causing chemicals in the petroleum & mining industry workers is the cause of diseases, such as chronic obstructive pulmonary disease (COPD), skin infections, muscle pains, chemical poisoning, cancer, and others.

The global occupational medicine market is expected to grow considerably during the forecast period, owing to various factors, such as rise in awareness related to occupational health, rapid growth in geriatric workforce, and favorable regulatory environment towards occupational medicine. However, increasing adoption of automation and artificial intelligence (AI) in industries and emerging small businesses along with change in industry structure are the key factors that are expected to hinder the market growth. On the contrary, emerging markets, such as China and India, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By application, the musculoskeletal disorder segment accounted for one-third share of the global occupational medicines market in 2017. Furthermore, the construction segment is anticipated to grow at the highest rate of 7.3% during the forecast period.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/1890

Key Findings of the Occupational Medicines Market:

- North America occupied almost one-fourth share of the global occupational medicine market.

- The construction segment is anticipated to grow with the highest CAGR throughout the forecast period.

- Europe is anticipated to occupy almost two-fifths market share of the global occupational medicine market by 2025.

- The Asia-Pacific region is anticipated to grow at the highest rate during the forecast period, followed by LAMEA.

Europe was the leading revenue contributor to the global occupational medicines market in 2017, owing to European regulatory framework for occupational medicines and occupational health that insists greatly on monitoring health and safety of workers in the work environment. However, the Asia-Pacific region is expected to grow at the highest CAGR of 7.4% from 2018 to 2025, owing to increase in disposable income, surge in research, development, and innovation activities, and rise in awareness towards occupational health.

The report provides an extensive competitive analysis and profiles of the key market players, such as

- Amgen, Inc.,
- AstraZeneca PLC,
- Bristol-Myers Squibb Company,
- Eli Lilly and Company,
- F. Hoffmann-La Roche Ltd,
- Johnson & Johnson,
- Nestl S.A. (Galderma S.A.),
- Novartis AG,
- Pfizer, Inc., and Sanofi.

The other players in the value chain (not included in the report) include Merck & Co., Inc., AbbVie, Inc., and GlaxoSmithKline plc.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4728

Table Of Content

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Surge in awareness about occupational health
3.4.1.2. Favorable regulatory environment
3.4.1.3. Rapid increase in aging workforce

3.4.2. Restraints

3.4.2.1. Emergence of small businesses and change in industry structure
3.4.2.2. Rise in incorporation of artificial intelligence (AI) and automation in the industry

3.4.3. Opportunity

3.4.3.1. Untapped potential of the emerging economies

Access Full Summery @ https://www.alliedmarketresearch.com/occupational-medicines-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.